Celator Pharma Cmn (CPXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,903 | -14,549 | -9,069 | -4,278 | -20,844 |
| Depreciation Amortization | 196 | 145 | 96 | 48 | 198 |
| Accounts receivable | 1,393 | 1,407 | 1,410 | 1,408 | 587 |
| Accounts payable and accrued liabilities | -462 | -1,007 | -667 | -122 | 492 |
| Other Working Capital | 608 | 109 | -132 | 1,056 | -26 |
| Other Operating Activity | 757 | 762 | -44 | -983 | 7,134 |
| Operating Cash Flow | $-14,412 | $-13,133 | $-8,405 | $-2,871 | $-12,460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | -15 | -4 | -2 | -41 |
| Investing Cash Flow | $-65 | $-15 | $-4 | $-2 | $-41 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,827 | 9,827 | 9,827 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -3,000 |
| Common Stock Issued | 14,930 | 104 | 104 | 104 | 32,521 |
| Other Financing Activity | -1,438 | -185 | -185 | 0 | -3,080 |
| Financing Cash Flow | $23,319 | $9,747 | $9,747 | $104 | $26,441 |
| Exchange Rate Effect | -18 | -9 | -4 | -8 | 1 |
| Beginning Cash Position | 23,590 | 23,590 | 23,590 | 23,590 | 9,648 |
| End Cash Position | 32,414 | 20,181 | 24,925 | 20,812 | 23,590 |
| Net Cash Flow | $8,824 | $-3,409 | $1,335 | $-2,778 | $13,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,412 | -13,133 | -8,405 | -2,871 | -12,460 |
| Capital Expenditure | -65 | -15 | -4 | -2 | -93 |
| Free Cash Flow | -14,477 | -13,147 | -8,409 | -2,874 | -12,552 |